Previous systematic reviews have demonstrated better results with enamel matrix derivative proteins (EMDP) as compared with open flap debridement (OFD) for the management of infrabony periodontal defects (IPD). The aim of this study was to determine whether these differences vary according to the follow-up and quality of the studies. Cochrane Central Register of Controlled Trials, Medline/PubMed, Lilacs, Embase and Web of Science electronic databases were searched up to August 2013 for randomized clinical trials.Eligible outcomes were changes in probing depth (PD), clinical attachment level (CAL),gingival recession (GR) and bone changes (BC). Studies with follow-up of 12 months showed differences of 0.97 mm (CI95% 0.52 -1.43) and 1.19 mm (CI95% 0.77 -1.60) for PD and CAL, respectively, favorable for EMDP. Studies with follow-up ≥ 24 months presented advantages of 1.11 mm (CI95% 0.74 -1.48) for CAL and 0.83 mm (CI95% 0.19 -1.48) for PD,with use of EMDP. Considering the quality of studies, those with low risk of bias showed lower difference between groups, presenting 0.8 mm (CI95% 0.24-1.36) for CAL, favorable for EMDP and without differences for PS (0.51 mm, CI95% -0.21 -1.23). In conclusion, follow-up time (< or > 2 years) and the risk of bias influence the results of treatment with EMDP in IPD.
Introduction
Destructive periodontal diseases are of multifactorial nature, with the subgingival biofilm being the main etiologic agent (1) . From this standpoint, the core approach for its therapy is to disorganize and disperse biofilm by mechanical means and, in some situations, with adjunct chemical agents (2) . Moreover, as additional therapeutic approach for affected sites with periodontal tissue destruction, there is the possibility of using regenerative techniques that aim at periodontal reconstruction, forming tissues that were previously lost due to disease progression (2) (3) (4) (5) .
Periodontal regeneration presupposes formation of periodontal ligament with collagen fibers inserted in new cementum and new alveolar bone (6) (7) (8) . With this purpose, diverse regenerative procedures have been developed and are available, such as guided tissue regeneration (GTR), associated or not with bone grafts or alloplastic materials (3, (9) (10) (11) . At present, advancements in molecular biology studies emphasized the importance of extracellular matrices in periodontal regeneration. Enamel matrix derivative proteins (EMDP), especially amelogenin, appear to play an important role in cementogenesis (12, 13) . Thus, in an endeavor to provide mimicking of what occurs during root development, an enamel matrix derivative of porcine origin has been used in an attempt to regenerate previously lost periodontal structures (13) (14) (15) (16) (17) .
Bosshardt (18) , in a systematic search of the literature, described the in vitro evidence of the biologic properties of EMDPs, such as stimulation of chemotaxis, cell proliferation, adhesion and survival, increase in the expression of growth factors, cytokines, extracellular matrix constituents and molecules involved in the regulation of bone formation. One of the indications for the use of EMDPs is for the management of infrabony periodontal defects (IPD). The use of EMDP in such defects has been histologically evaluated in animals (19, 20) and in humans (8, 15, 21, 22) with promising results regarding periodontal regeneration, and their clinical results have been shown to be significantly better than those of their comparative controls (14, 15, (23) (24) (25) (26) (27) (28) (29) .
Esposito et al. (30) and Koop et al. (31) demonstrated by systematic reviews that the use of EMDP may be a feasible clinical alternative with slightly superior clinical results to those of conventional periodontal treatment for the management of IPD. In spite of finding great variability in the results, neither one of them made an analysis of the clinical results, comparing differences in the follow-up time of the studies.
In view of the afore-mentioned issues, the propose of the present systematic review with meta-analysis was to test the null hypothesis that there would be no differences among studies with up to 12 months or 24 months or more of follow-up.
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Material and Methods
Research Questions
The present study addressed two specific questions: 1) What was the effect of EMDP when compared with open flap debridement (OFD) in IPD in a period of at least 12 months, with regards to alterations in probing depth (PD) and clinical attachment levels (CAL)? 2) Are these results maintained over 24 months?
Search Strategy
The search strategy was attained in electronic databases (Medline -Pubmed, LILACS, Cochrane Central Register of Controlled Trials, Embase and Web of Science). The search was conducted without time limit up to August 2013. The following strategy was conducted in PubMed. Adaptations of this strategy were done for the other databases. In the LILACS database, Portuguese and Spanish languages were used to set up the search strategy.
[ 
Eligibility Criteria
To be considered eligible, studies should have a Randomized Controlled Trial (RCT) design, split-mouth or parallel-arm trials, with one intervention group using EMDPs, and the control group having instrumentation performed with surgical access (OFD) with or without a placebo. Additional to that, a minimum follow-up period of 12 months; studies should have been performed in humans with chronic or aggressive periodontitis with treatment of infra-bony lesions on 1, 2 or 3 walls; PD and CAL should have been evaluated as main outcomes. In addition, GR (Gingival recession) and/or BL (bone loss) could be present as secondary evaluation(s); no additional regenerative procedure should have been used; studies should be published in any language.
Selection of Studies
After this first stage of general search, two independent examiners (FGS and FBZ) evaluated all of these studies. In the first stage, studies were included or not by their titles; in the second, by their abstract, and in the third stage, after reading of the entire paper ( Fig. 1) . At the end of each stage, the examiners met and discussed divergences until they reached a consensus. The papers were selected according to pre-defined eligibility criteria.
Quality Scores of Selected Studies
A. Was there a sample size calculation? 0 No/not mentioned; 1 Yes, but not confirmed by calculation; 2 Yes, confirmed / B. Randomizations were categorized as (0) unclear, when the method was not reported or explained; (1) inadequate, when other methods were used (such as alternate assignment, hospital number, odd/even birth date, etc.) and (2) adequate, when a table of random numbers or a tossed coin or shuffled cards were used / C. Allocation concealment was categorized as (0): unclear, when the method was not reported or explained; (1) If disagreement occurred, a discussion was held until consensus was reached. The total score for the study was counted. Studies with score <07 points were considered to have high risk of bias, scores between 07-10 moderate risk of bias, and scores >10 with low risk of bias.
Data Extraction
In each study, data related to clinical outcomes at baseline, in final examinations and differences between treatments were evaluated. For data analysis, Review 
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Collaboration) was used. Mean differences and 95% Confidence Intervals of differences (95%CI) were calculated for PD and CAL. Random effects models were used for continuous data. Statistical heterogeneity was evaluated by Cochran's test, where p values below 0.1 were considered heterogeneous. The degree of inconsistency was verified by the I 2 test. An analysis by sub-groups was performed considering the follow-up time (studies ≥24 months / up to 12 months follow-up) and the risk of bias (high and moderate risk/low risk) using the random effects model due to the heterogeneity detected (Figs. 2, 3, 4 and 5) .
Results
In the first stage, 1029 studies (Lilacs: 247 studies, Pubmed: 417 studies, Web of Science: 304 studies, Embase: 55, Cochrane: 06 studies) were selected. Out of these, 819 were excluded by the title, 63 by the abstract, 141 were duplicated; finally, 20 were retrieved for complete reading (Fig. 1) . Moreover, 1 study was excluded after this last stage, so that 19 eligible studies remained.
Study Characteristics
Of the 19 studies included, nine had a split-mouth design -six with a follow-up period of 12 months (14, 16, 23, 27, 28, 34) and three with duration of over 24 months (15, 35, 36) -and ten had a parallel design -five with a follow-up period of 12 months (10, 17, (37) (38) (39) and five with a follow-up period of over 24 months (24, 25, 29, 40, 41) . Regarding the evaluated outcomes, PD and CAL were evaluated in all the studies, gingival recession (GR) was additionally evaluated in eight studies (15, 16, 24, 25, 29, 36, 39, 41) and bone filling in twelve studies (10, (14) (15) (16) (23) (24) (25) 27, 29, 36, 39, 41) . As to the methodological quality, five studies presented low risk of bias (7, 16, 17, 25, 41) , twelve had moderate risk (10, 14, 23, 24, 27, 28, (34) (35) (36) (37) 39, 40) and two had high risk (29, 38) of bias.
Meta-Analysis Results
According to the results of the meta-analysis of subgroups with inclusion of the 19 studies, considering the probing depth, high statistical heterogeneity was detected in the analysis of PD in studies with up to 12 months (p<0.00001 I 2 =91%) or over 24 months of follow-up (Fig. 2) , (p<0.00001 I 2 =82%). In the analysis of CAL, there was high heterogeneity in studies of 12 months (p<0.00001 I 2 =86%) and low heterogeneity in those with over 24 months of follow-up (Fig. 3) , (p=0.08 I 2 =45%). Similar parameters were observed considering probing depth, high statistical heterogeneity was detected in the analysis of PD in studies with moderate and high bias (p<0.00001 I 2 =88%) and low bias studies (Fig. 4) , (p<0.003 I 2 =75%). In the analysis of CAL, there was high heterogeneity in studies with moderate and high bias (p<0.00001 I 2 =85%) and in those with low bias (Fig. 5) , (p=0.01 I 2 =70%). In the general results of the meta-analysis, EMDPs presented statistically better results than those of their respective controls, with a mean difference of 0.93 mm (CI95% 0.57 -1.29) and 1.15 mm (CI95% 0.74 -1.48) for PD and CAL, respectively. Studies with 12 months of follow-up presented a mean difference of 0.97 mm (CI95% 0.52 -1.43) for PD (Fig. 2) and 1.19 mm (CI95% 0.77 -1.60) for CAL (Fig. 3) , favorable to EMDPs. In studies with over two years of follow-up, the mean differences were also favorable to EMDPs with 0.93 mm (CI95% 0.57 -1.29) and 1.11 mm (CI95% 0.84 -1.48) for PD (Fig. 2) and CAL (Fig. 3) , respectively. Considering the risk of bias, studies with high and moderate risk of bias showed differences favorable to EMDPs, of the magnitude of 1.06 mm (CI95% 0.52 -1.60) Figure 5 . Meta-analysis for attachment level considering only studies with high/moderate and low risk of bias. 
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for PD (Fig. 4) and 0.99 mm (CI95% 0.63 -1.35) for CAL (Fig. 5) . However, in studies with low risk of bias, the EMDPs showed lower results in favor of EMDPs group for CAL 0.80 mm (CI95% 0.24 -1.36) (Fig. 5) without differences for PD (0.51 mm CI95% -0.21 -1.23) (Fig. 4) . Figure 6 shows the funnel plot for PD and NIC evidencing the possibility of publication bias since there is a clear trend of studies to show differences favoring EMDPs.
Discussion
The present systematic review assessed clinical results of EMDP as compared to OFD in IPDs and demonstrated that the published literature indicates slight benefits with the use of EMDPs, especially when overtime results are considered, as well as taking the quality of the studies into consideration. Information obtained by means of periodontal probing, radiographs and re-entry procedures are limited in determining the quality, quantity and nature of the newly formed supporting tissues (42) . Alterations in probing depth reflect inflammatory changes and clinical attachment gains that may be obtained without new formation of the periodontium, due to resolution of inflammation, bone filling, collagen fiber reorganization and formation of the long junctional epithelium. Thus, probing does not offer direct proof of periodontal neoformation and therefore does not constitute an adequate instrument for the evaluation of regenerative processes. However, clinicians use probing as the gold standard for evaluating patients. This means that clinical evaluations are useful, but cannot assure regeneration. Bone levels after the use of EMDP may be compared with the initial bone levels as an interesting outcome. Eleven studies (10, 15, 16, (23) (24) (25) 27, 29, 36, 39, 41) observed bone filling in radiographs, and in only one study it was performed in re-entry surgeries (14) . Nevertheless, it is important to point out that bone measurements do not reflect connective attachment levels. In addition, bone height, density and volume may be estimated pre-and post-treatment, however without reflecting alterations in connective tissue (42, 43) . Therefore, it is evident that clinical and radiographic methods are not safe in the determination of the healing pattern that occurs after regenerative therapy.
Histologic evaluation is the only reliable method for determining the efficacy of regenerative therapies. It allows for evaluation of all the components of the periodontium and thus, will faithfully determine whether the clinical results represent neoformation of the periodontal tissues or any form of repair. Due to ethical considerations, histologic evaluation is mostly performed in animal models rather than in humans. Sculean et al. (20) demonstrated that regeneration is attained in monkeys after the use of EMDP, however with varied extensions in the different types of produced defects. Using dogs, Alhezaimi et al. (19) demonstrated complete regeneration (new cement, inserted ligament and bone tissue) in only 3 of the 15 defects treated with EMDP, with an extension of 58%±4% in height. The other sites treated with EMDP exhibited formation of new cement and periodontal ligament only, in varied extensions, and this fact also occurred in 20% of the control sites. Human histological studies with EMDP comprised limited number of patients and therefore should not be considered in terms of validity. The meta-analysis performed in this review demonstrated results for PD and CAL that were consistently favorable to the EMDP group. However, high heterogeneity was detected for PD, irrespective of the period of follow-up time, and for CAL this occurred in studies with follow-up periods of less than 12 months. Venezia et al. (44) also found results favorable to the enamel matrix derivatives, however, their systematic review with meta-analysis presents some methodological issues that prevent safe extrapolation of their findings. The obtained results are in line with two well-conducted systematic reviews about the same subject (30, 31) . However, differently from these two reviews, this study performed analyses by subgroups, considering follow-up time, suggesting that the magnitude of differences between the use of EMDP and OFD considerably decreases over time. Thus, it could be hypothesized that in some of the sites treated with EMDP, the formation of LJE occurred after the use of EMDP, and thus they presented a healing pattern similar to that of the control groups. Moreover, the factor that would justify the results of greater clinical magnitude in the first 12 months is that the EMDPs presented some immediate biologic effects, and these tended to diminish overtime, because although some of the sites treated with EMDP presented regeneration, this occurred in a reduced extension of the IPD.
Considering that studies with a stricter methodological approach are more reliable, when one considered only those with low risk of bias, the differences for CAL become less favorable to the EMDPs, without differences for PD. Studies with low risk of bias follow a strict research protocol which allows smaller systematic errors influence the research, decreasing the overestimation of the results (32) .
The variability of the results is clear when the variations in reductions in probing depth and clinical attachment level are evaluated. It could be hypothesized that this heterogeneity may be explained by the fact that some studies used antibiotics (14) (15) (16) 24, 25, 27, 29, 34 ) and others did not (10, 17, 23, 26, 28, 30, 35) , by the variable surface treatments, inclusion of smokers (10, (14) (15) (16) (17) (23) (24) (25) 28, 29, 34, 35) , initial depth of defects and number of remaining bone walls, use of placebo gel in some studies (10, 15, 16, 27, 34) and not in others (14,17,23-26,28,29,35 ), differences in methodological quality, in addition to other variables that could influence the results, such as the surgical technique, quality of instrumentation and biofilm control performed by the patients (45) .
Evidence has demonstrated that the topography of the IPD is directly related to its regenerative potential. Twoor three-wall defects are more easily regenerated when compared with defects with one wall, due to the presence of a larger number of bone walls and, consequently, a larger number of potential sources (periodontal and endosteal ligament) of cells able to differentiate into cementoblasts, osteoblasts and fibroblasts of the periodontal ligament (46) . Moreover, the vertical and horizontal components of defects exert an influence on their regenerative potential. Deeper defects compete with more favorable prognoses, and angles smaller than 45 o formed between the root surface and bone wall show more predictability as regards regeneration than wider defects (>45 o ) (47) . From this aspect, differences in the topographies of defects may also explain the high variability of the results, since defects with 1 and 2 walls were also included in the treatment groups.
In spite of the high heterogeneity detected for PD in studies with less than one or more than two years of followup, evaluation of the heterogeneity of CAL demonstrated differences in variability with the time of follow-up, in which studies with a follow-up period of over two years showed little variability in the results. This shows that irrespective of the methodological differences among the studies, CAL appears to be the most reliable outcome for evaluating the stability of the results in studies in which the use of EMDP in IPD is compared. A possible explanation is due to the possible fluctuations in PD resulting from edema or gingival margin recession, influenced by gingival margin inflammation, which are also influenced by the morphology of the subjacent bone wall. On the other hand, CAL is more related to the healing process in the apical portion of the IPD, being mainly influenced in the first two years by morphological variability of the defects and inter-individual biological variations (47) .
The results relative to PD and CAL were shown to be consistently favorable to treatment with EMDP. However, when the magnitude of these differences is discussed one can observe advantages that do not exceed 1.17 mm for the evaluated parameters in studies with follow-up periods of over 24 months. Therefore, the clinical relevance of these differences can be questioned both from a magnitude point of view (since they are similar to probing margin of error) as well as from a longitudinal point of view, since the magnitude of the differences tends to decrease. Killoy (48) put forward some guidelines for evaluating whether the magnitude of the differences between treatments should be considered clinically significant: 1) Does the proposed treatment change the prognosis of the case? 2) Does it diminish or simplify future treatment? 3) Does it reduce the need for more aggressive therapies? 4) Does it modify or simplify the maintenance therapy? 5) Does it facilitate restorative treatment both for the patient and professional? 6) Is the cost-benefit ratio favorable? Having stated this, one also finds that there is still a lack of evidence that answer several of these questions when the use of EMDP is considered for the treatment of IPD. Studies concerning true endpoints as tooth loss, quality of life, etc., are therefore warranted.
One important aspect that needs to be put into perspective concerning the present study is publication bias. It is well known from the literature that studies that do not display statistically significant differences among tested groups tend not to be published. Also, studies that are supported by the industry have higher chance to present significant results. This factor was assessed in the present review in which it seems to be a clear trend of almost published studies to show differences favoring EMDP. Thus, it should be kept in mind while interpreting the present results, that it may be possible that additional studies, especially those without relevant benefits of EMDP have been performed and are not published due to publication bias (49) .
It seems that despite being a goal, complete and predictable regeneration of the periodontium in infra-bony lesions with the use of EMDP apparently continues to be an unattainable objective. The results relative to PD and CAL are slightly superior to those obtained with conventional treatment. Therefore, in spite of EMDPs being a therapeutic alternative for the management of infrabony lesions, the variability, reduction in clinical differences after 2 years and cost-benefit of the procedure, should form part of the discussion with the patient for the decision-making process. In conclusion, EMDP presents slightly better clinical outcomes than OFD, which possibly decrease overtime. Additionally, the effects are lower in studies with lower risk of bias.
Resumo
Revisões sistemáticas prévias tem demonstrado melhores resultados com proteínas derivadas da matriz de esmalte (PDME) em comparação a retalho de espessura total (RET) para o manejo de defeitos periodontais infraósseos (DPI). O objetivo desse estudo foi determinar se essas diferenças variam de acordo com o tempo de acompanhamento e com a qualidade dos estudos. As bases de dados Cochrane Central Register of Controlled Trials, MEDLINE (PubMed), Lilacs, Embase e Web of Science foram pesquisadas sem limitação de tempo ate agosto de 2013 para ensaios clínicos randomizados. Os desfechos elegíveis foram alterações na profundidade de sondagem (PS), nível de inserção clinica (NIC), recessão gengival (RG) e alterações ósseas (AO). Resultados: Estudos com acompanhamento de ate 12 meses mostraram diferenças de 0.97 mm (CI95% 0.52 -1.43) e 1.19 mm (CI95% 0.77 -1.60) para PS e NIC, favoráveis a PDME, respectivamente. Estudos com acompanhamento ≥24 meses demonstraram vantagens de 1.11 mm
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(CI95% 0.74 -1.48) para NIC e 0.83 mm (CI95% 0.19 -1.48) para PS, com o uso de PDME. Considerando a qualidade dos estudos, publicações com baixo risco de viés exibiram menores diferenças entre os grupos apresentando 0.8 mm (CI95% 0.24-1.36) para o NIC, sem diferenças para PS (0.51 mm, CI95% -0.21 -1.23). Pode-se concluir que o tempo de acompanhamento (< ou > 2anos) e o risco de viés são variáveis que influenciam nos resultados do tratamento com PDME em DPIO.
